用于癌症治疗的瘤响应纳米药物:设计原则和治疗进展
Yan Liu1, Yinan Wang1, Ahequeli Gemingnuer1
1School of Pharmacy, Heilongjiang University of Chinese Medicine, NO.24 Heping Road, Harbin 150040, People's Republic of China.
Biomedical materials (Bristol, England)
|July 31, 2025
概括
响应瘤微环境 (TME) 的纳米药物通过在瘤部位释放药物来提供向癌症治疗. 本综述详细介绍了对TME敏感纳米药物的进展,以增强癌症免疫治疗和减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 响应瘤微环境 (TME) 的纳米药物代表了精确癌症治疗的重大进步.
- 这些纳米药物利用刺激反应性质用于瘤部位内的向输送和受控释放.
- 这种方法旨在提高治疗疗效,并最大限度地减少系统性副作用.
研究的目的:
- 为癌症免疫治疗中对TME敏感纳米药物的最新发展提供全面的概述.
- 探索这些纳米药物中使用的各种刺激反应机制 (pH,活性氧物种,缺氧,酶,ATP).
- 讨论这些先进疗法的临床转化所面临的挑战和未来方向.
主要方法:
- 在癌症免疫治疗中对TME敏感纳米药物的文献综述.
- 对刺激反应机制及其对免疫反应的影响的分析.
- 检查临床翻译挑战和未来的研究途径.
主要成果:
- 响应TME的纳米药物显示出改善向输送和控制药物释放的潜力.
- 各种刺激反应策略可以有效地增强抗瘤免疫反应.
- 临床翻译的主要挑战包括制造,稳定性和监管障碍.
结论:
- 响应TME的纳米药物是促进癌症免疫治疗的有希望的战略.
- 需要进一步的研究来克服临床翻译障碍并优化治疗结果.
- 这一综述为开发下一代瘤响应纳米药物提供了基础.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.8K
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.3K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
